Taiho Pharmaceuticals Co., Ltd. et al. v. Pharmascience Inc.
2024
T-1309-24
Pending
6(1) PMNOC
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,861,480; 2,914,999 and 2,985,006 (trifluridine/tipiracil).
Counsel to:
Pharmascience Inc.
The decision is reported
here.
Meet the team
Warren Sprigings
Partner
David Reive
Partner
Mingquan Zhang, Ph.D.
Associate
Meghan A. Dureen, Ph.D.
Counsel
Alexandre Lavoie
Associate
Raenaud Tiwari
Associate
Nancy You
Associate